Meser M. Ali

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways”.

Glioblastoma: Targeting Angiogenesis and Tyrosine Kinase Pathways

Novel Approaches in Cancer Study(2020)10.31031/nacs.2020.04.000596

N/A

0DataRank · unranked

15 citations

Meser M. Ali

Dendrimer-Based Nanomedicine (Paramagnetic Nanoparticle, Nanocombretastatin, Nanocurcumin) for Glioblastoma Multiforme Imaging and Therapy

Novel Approaches in Cancer Study(2021)10.31031/nacs.2021.06.000639

N/A

0DataRank · unranked

6 citations

Meser M. Ali

Energy Harvesting by Mesoporous Reduced Graphene Oxide Enhanced the Mediator-Free Glucose-Powered Enzymatic Biofuel Cell for Biomedical Applications

ACS Applied Materials & Interfaces(2022)10.1021/acsami.1c25211

N/A

0DataRank · unranked

32 citations

Erik Marquez, Grace B. Djokoto, Maurice Parker, Talia Weinstein, William Ghann +10 more

Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model

Cancers(2023)10.3390/cancers15204931

N/A

0DataRank · unranked

20 citations

Branislava Janic, Tasnim Rahman, Harshit Singh, Haythem Ali, Ramandeep Rattan +3 more

Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy

Cells(2024)10.3390/cells13221924

N/A

0DataRank · unranked

67 citations

Mahesh Kumar Yadab, Meser M. Ali, Md. Ataur Rahman

Recent Treatment Strategies and Molecular Pathways in Resistance Mechanisms of Antiangiogenic Therapies in Glioblastoma

Cancers(2024)10.3390/cancers16172975

N/A

0DataRank · unranked

25 citations

Meser M. Ali, Md. Ataur Rahman

Overcoming standard-of-care resistance in glioblastoma using nanoparticle-based drug delivery targeting the autophagy pathway

Biochemical Pharmacology(2025)10.1016/j.bcp.2025.117302

N/A

0DataRank · unranked

5 citations

Mahesh Kumar Yadab, Meser M. Ali, Md. Ataur Rahman

A novel HPβCD-Cu(DDC)2 delivery system in patient derived orthotopic xenograft targeting MGMT-mediated temozolomide resistance in glioblastoma

Scientific Reports(2025)10.1038/s41598-025-14731-4

N/A

0DataRank · unranked

3 citations

Md. Ataur Rahman, Mahesh Kumar Yadab, Sunalee Gonawala, Ana C. deCarvalho, James R. Ewing +3 more

A modern approach to glioblastoma using temozolomide and nanoparticles carrier drug: a standard care of combination therapy and treatment

Biochemical Pharmacology(2025)10.1016/j.bcp.2025.117276

N/A

0DataRank · unranked

1 citations

Mahesh Kumar Yadab, Meser M. Ali, Md. Ataur Rahman